PRESENT Podiatry Online CME & Conferences 8/26/18, 9)50 PM

Search
Residency
Lecture Hall
Conferences
eZines
eTalk
More

CME Progress
!
Custom Therapy Options in the Modern Podiatry Practice

Pre-Test

1. * Compounding medications can improve therapeutic outcomes by doing which of the following?

A. Avoiding dyes

B. Making medication palatable

CME Progress

C. Avoiding side effects

D. All of the above

1.
Compounding medications can improve therapeutic outcomes by doing which of the following?

2. * When creating dyes

A. Avoiding a compound medication from an oral product how much medication should go
into the transdermal product?

B. Making medication palatable

* A. The bioavailable percentage

C. Avoiding
B. ½ side effects
the dose

D. All of the above

https://podiatry.com/lecturehall/wizard/4500 Page 1 of 4

2.
When creating a compound medication from an oral product how much medication should go
PRESENT Podiatry Online CME & Conferences 8/26/18, 9)50 PM

C. ¼ of the dose

D. The same dose

3. * Which of the following statements about trasndermal drug delivery is false?

A. Its bypasses the liver and kidneys

B. It may cause GI upset

C. ¼ of the dose

C. There are no systemic side effects

D. The same dose

D. It must be applied to intact skin

3.
Which of the following statements about trasndermal drug delivery is false?

4. * In Podiatry compounding
A. Its bypasses the livermedications
and kidneys can be used to treat which of the following conditions?

A. Warts and calluses

B. It may cause GI upset
*
B. Fungal infections
C. There are no systemic side effects

C. Poor circulation
D. It must be applied to intact skin

D. All of the above

4.
In Podiatry compounding medications can be used to treat which of the following conditions?

5. * When compounding
A. Warts a tablet medication to a transdermal patch the best place for patch
and calluses
placement for quicker absorption is:

B. Fungal infections
* A. Torso

C. Poor circulation
B. Thigh

D. All of the above

https://podiatry.com/lecturehall/wizard/4500 Page 2 of 4

5.
PRESENT Podiatry Online CME & Conferences 8/26/18, 9)50 PM

C. Wrist

D. Gluteal area

6. * Which of the following is a common compounding dosage form?

A. Oral capsules

B. Sublingual drop
C. Wrist

C. Lollipops
D. Gluteal area

D. All of the above

6.
Which of the following is a common compounding dosage form?

7. * Guaifensesin, an expectorant can also be used transdermally for what purpose?

A. Oral capsules

A. Neuropathic agent
B. Sublingual drop
*
B. Antiemetic
C. Lollipops

C. Muscle relaxant
D. All of the above

D. Promote granulation tissue

7.
Guaifensesin, an expectorant can also be used transdermally for what purpose?

8. * Which of the following

A. Neuropathic agentstatements about compounding is false?

A. Compounding creates individualized medication

B. Antiemetic
*
B. There are limited dosages and forms available
C. Muscle relaxant

C. Compounding can create medication to be administered directly to the sight of action

D. Promote granulation tissue
https://podiatry.com/lecturehall/wizard/4500 Page 3 of 4

8.
PRESENT Podiatry Online CME & Conferences 8/26/18, 9)50 PM

D. Compounding creates a unique dosage form designed for specific problem

9. * Which medication can be used for wound care to promote granulation tissue and increase
collagen synthesis?

A. Phenytoin

B. Misoprostol

D.
C. Compounding
Sucralfate creates a unique dosage form designed for specific problem

9. D. Cromolyn Sodium
Which medication can be used for wound care to promote granulation tissue and increase
collagen synthesis?

10. * Which medication can be used in compounding as a MU agonist to give an opioid like effect?
A. Phenytoin

* A. Loperamide
B. Misoprostol

B. Ketamine
C. Sucralfate

C. Nifedipine
D. Cromolyn Sodium

D. Lidocaine
10.
Which medication can be used in compounding as a MU agonist to give an opioid like effect?

A. Loperamide

* - Required
B. Ketamine
*
Submit
C. Nifedipine

D. Lidocaine

https://podiatry.com/lecturehall/wizard/4500 Page 4 of 4